Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Smither John W
Relationship:   Director
City:   Calabasas
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   89,084    

Indirect Shares

   176,353      
Direct Value   $120,228    

Indirect Value

   $1,255,561      
Total Shares   265,437      
Total Value   $1,375,789      


Sienna Biopharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $100,921 Effector Therapeutics Ord Shs $0 Genelux Corp $19,307 Sienna Biopharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $100,921 Effector Therapeutics Ord Shs $0 Genelux Corp $19,307
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -78.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Kythera Biopharmaceuticals Inc KYTH Chief Financial Officer 2015-10-01 0 2015-10-01 0    Premium*  
            Sienna Biopharmaceuticals, Inc. SNNA 2019-01-01 46,657 2019-01-01 34,961    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT Chief Financial Officer 2024-02-13 11,365 2024-02-13 141,392    Premium*  
            Effector Therapeutics Ord Shs EFTR Director 2021-08-25 24,142 2021-08-25 0    Premium*  
            Genelux Corp GNLX Director 2023-09-13 6,920 2023-09-11 0    Premium*  
* Premium Members only  

Records found :    99         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-03-10 4 OE $1.68 $840 D/D 500 46,821 0 -
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-03-10 4 AS $32.90 $16,450 D/D (500) 46,321 0 %
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-02-10 4 OE $1.68 $1,260 D/D 750 25,948 0 -
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-02-10 4 AS $35.64 $26,730 D/D (750) 25,198 0 %
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-03-01 4 AS $34.20 $26,440 D/D (773) 24,425 0 %
GNLX Genelux Corp Director   –       •      –    2023-09-13 4 S $20.78 $18,702 D/D (900) 6,920 0 %
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-01-29 4 AS $38.00 $38,000 I/I (1,000) 18,416 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-02-17 4 AS $40.00 $40,000 I/I (1,000) 17,416 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-02-18 4 AS $42.00 $42,000 I/I (1,000) 16,416 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-09-18 4 S $74.95 $78,997 D/D (1,054) 3,368 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-09-18 4 OE $8.22 $8,664 D/D 1,054 4,422 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-01-21 4 OE $5.90 $6,638 D/D 1,125 11,325 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-01-21 4 AS $42.54 $47,856 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-14 4 OE $5.90 $6,638 D/D 1,125 11,325 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-14 4 AS $50.00 $56,250 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-03-20 4 OE $5.90 $6,638 D/D 1,125 11,325 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-03-20 4 AS $43.78 $49,253 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-12-16 4 OE $1.35 $1,620 D/D 1,200 10,200 0 -
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2020-09-29 4 AS $30.00 $37,500 I/I (1,250) 98,715 0 %
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-01-19 4 AS $30.00 $37,500 I/I (1,250) 93,715 0 %
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-02-01 4 AS $35.00 $43,750 D/D (1,250) 25,198 0 %
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-02-01 4 OE $1.68 $2,101 D/D 1,250 26,448 0 -
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-03-10 4 AS $32.90 $41,125 I/I (1,250) 86,715 0 %
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-06-26 4 GD $0.00 $0 I/I 1,400 6,216 0 -
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2020-12-14 4 OE $1.68 $2,521 D/D 1,500 26,698 0 -
  99  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us